JP2015503524A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015503524A5 JP2015503524A5 JP2014549204A JP2014549204A JP2015503524A5 JP 2015503524 A5 JP2015503524 A5 JP 2015503524A5 JP 2014549204 A JP2014549204 A JP 2014549204A JP 2014549204 A JP2014549204 A JP 2014549204A JP 2015503524 A5 JP2015503524 A5 JP 2015503524A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- membrane
- eluate
- interest
- ion exchange
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000012528 membrane Substances 0.000 claims description 45
- 238000000034 method Methods 0.000 claims description 30
- 239000000356 contaminant Substances 0.000 claims description 17
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 15
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 15
- 229920001184 polypeptide Polymers 0.000 claims description 14
- 238000000746 purification Methods 0.000 claims description 12
- 238000005341 cation exchange Methods 0.000 claims description 11
- 229920000831 ionic polymer Polymers 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 8
- 239000003011 anion exchange membrane Substances 0.000 claims description 7
- 239000003014 ion exchange membrane Substances 0.000 claims description 7
- 239000000872 buffer Substances 0.000 claims description 6
- 229920002873 Polyethylenimine Polymers 0.000 claims description 5
- 238000011210 chromatographic step Methods 0.000 claims description 5
- 238000005349 anion exchange Methods 0.000 claims description 4
- 238000005571 anion exchange chromatography Methods 0.000 claims description 4
- 238000005277 cation exchange chromatography Methods 0.000 claims description 4
- 150000002500 ions Chemical class 0.000 claims description 3
- 239000003463 adsorbent Substances 0.000 claims description 2
- 238000004255 ion exchange chromatography Methods 0.000 claims 6
- 238000011091 antibody purification Methods 0.000 claims 3
- 239000003937 drug carrier Substances 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000011148 porous material Substances 0.000 claims 1
- 108091008038 CHOP Proteins 0.000 description 8
- 102100021246 DDIT3 upstream open reading frame protein Human genes 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 239000000463 material Substances 0.000 description 6
- 101100075829 Caenorhabditis elegans mab-3 gene Proteins 0.000 description 5
- 239000012535 impurity Substances 0.000 description 5
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 4
- 229930182566 Gentamicin Natural products 0.000 description 4
- 229960002518 gentamicin Drugs 0.000 description 4
- 238000001042 affinity chromatography Methods 0.000 description 2
- 230000002860 competitive effect Effects 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 238000001742 protein purification Methods 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 101100476210 Caenorhabditis elegans rnt-1 gene Proteins 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000002647 aminoglycoside antibiotic agent Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000009881 electrostatic interaction Effects 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- -1 salt ions Chemical class 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161579285P | 2011-12-22 | 2011-12-22 | |
| US61/579,285 | 2011-12-22 | ||
| PCT/US2012/070373 WO2013096322A1 (en) | 2011-12-22 | 2012-12-18 | Ion exchange membrane chromatography |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018023128A Division JP2018109024A (ja) | 2011-12-22 | 2018-02-13 | イオン交換膜クロマトグラフィー |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015503524A JP2015503524A (ja) | 2015-02-02 |
| JP2015503524A5 true JP2015503524A5 (enExample) | 2017-06-15 |
| JP6605202B2 JP6605202B2 (ja) | 2019-11-13 |
Family
ID=47430154
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014549204A Active JP6605202B2 (ja) | 2011-12-22 | 2012-12-18 | イオン交換膜クロマトグラフィー |
| JP2018023128A Withdrawn JP2018109024A (ja) | 2011-12-22 | 2018-02-13 | イオン交換膜クロマトグラフィー |
| JP2019193276A Active JP7402011B2 (ja) | 2011-12-22 | 2019-10-24 | イオン交換膜クロマトグラフィー |
| JP2021102974A Active JP7359807B2 (ja) | 2011-12-22 | 2021-06-22 | イオン交換膜クロマトグラフィー |
| JP2022050501A Pending JP2022101557A (ja) | 2011-12-22 | 2022-03-25 | イオン交換膜クロマトグラフィー |
Family Applications After (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018023128A Withdrawn JP2018109024A (ja) | 2011-12-22 | 2018-02-13 | イオン交換膜クロマトグラフィー |
| JP2019193276A Active JP7402011B2 (ja) | 2011-12-22 | 2019-10-24 | イオン交換膜クロマトグラフィー |
| JP2021102974A Active JP7359807B2 (ja) | 2011-12-22 | 2021-06-22 | イオン交換膜クロマトグラフィー |
| JP2022050501A Pending JP2022101557A (ja) | 2011-12-22 | 2022-03-25 | イオン交換膜クロマトグラフィー |
Country Status (21)
| Country | Link |
|---|---|
| US (3) | US10364268B2 (enExample) |
| EP (2) | EP3492486A1 (enExample) |
| JP (5) | JP6605202B2 (enExample) |
| KR (3) | KR20200008022A (enExample) |
| CN (2) | CN108892706A (enExample) |
| AR (1) | AR089362A1 (enExample) |
| AU (3) | AU2012355356B2 (enExample) |
| BR (1) | BR112014015101A8 (enExample) |
| CA (1) | CA2859376C (enExample) |
| ES (1) | ES2697676T3 (enExample) |
| HR (1) | HRP20181846T1 (enExample) |
| IL (2) | IL267585B (enExample) |
| MX (2) | MX360453B (enExample) |
| MY (1) | MY172426A (enExample) |
| PL (1) | PL2794635T3 (enExample) |
| RU (1) | RU2648999C2 (enExample) |
| SG (1) | SG11201403437TA (enExample) |
| SI (1) | SI2794635T1 (enExample) |
| TR (1) | TR201815709T4 (enExample) |
| WO (1) | WO2013096322A1 (enExample) |
| ZA (2) | ZA201404593B (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2794635T3 (pl) * | 2011-12-22 | 2019-02-28 | F.Hoffmann-La Roche Ag | Membranowa chromatografia jonowymienna |
| US9951101B2 (en) | 2013-12-12 | 2018-04-24 | Emd Millipore Corporation | Protein separations using an acrylamide containing filter |
| US10654933B2 (en) * | 2013-12-27 | 2020-05-19 | Chugai Seiyaku Kabushiki Kaisha | Method for purifying antibody having low isoelectric point |
| CN104693303B (zh) * | 2015-02-28 | 2018-03-13 | 苏州金盟生物技术有限公司 | 一种蛋白制品中的核酸去除方法 |
| ES2964640T3 (es) | 2015-08-13 | 2024-04-08 | Amgen Inc | Filtración en profundidad cargada de proteínas de unión al antígeno |
| GB201711481D0 (en) | 2017-07-17 | 2017-08-30 | Ucb Biopharma Sprl | Protein purification |
| EP3546475A1 (en) * | 2018-03-27 | 2019-10-02 | Sanofi | Full flow-through process for purifying recombinant proteins |
| US10792618B2 (en) | 2018-06-19 | 2020-10-06 | Sartorius Stedim Biotech Gmbh | Particle separation and/or purification of a fluid |
| KR102140531B1 (ko) * | 2018-08-07 | 2020-08-04 | (주)휴온스 | Gly-Tβ4의 제조방법 |
| US12103949B2 (en) * | 2018-08-14 | 2024-10-01 | Bristol-Myers Squibb Company | Protein recovery |
| GB201815405D0 (en) * | 2018-09-21 | 2018-11-07 | Fujifilm Mfg Europe Bv | Membranes suitable for detecting, filtering and/or purifying biomolecules |
| US12306152B2 (en) | 2018-12-21 | 2025-05-20 | Solventum Intellectual Properties Company | Method for testing a chromatography device used for ion exchange |
| AR119264A1 (es) * | 2019-06-05 | 2021-12-09 | Genentech Inc | Método para reutilización de cromatografía |
| AU2021210905A1 (en) * | 2020-01-24 | 2022-09-01 | Mural Oncology, Inc. | Methods of purification |
| US11416468B2 (en) * | 2020-07-21 | 2022-08-16 | International Business Machines Corporation | Active-active system index management |
| CN116425826A (zh) * | 2021-12-30 | 2023-07-14 | 广州百济神州生物制药有限公司 | 一种快速纯化质量样品的方法 |
| CN116371011B (zh) * | 2023-05-26 | 2023-08-18 | 湖南杰萃生物技术有限公司 | 一种从桑叶中提取黄酮和生物碱的方法 |
| CN117866038B (zh) * | 2024-03-11 | 2024-05-28 | 北京百力格生物科技有限公司 | 纯化含有宿主核酸的带亲和标签的酸性蛋白的方法 |
| CN122057257A (zh) * | 2026-04-16 | 2026-05-19 | 苏州小路生物科技有限公司 | 一种用于多特异性抗体分步纯化的双入口捕获柱切换装置 |
Family Cites Families (79)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE266710C (enExample) | ||||
| US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
| USRE30985E (en) | 1978-01-01 | 1982-06-29 | Serum-free cell culture media | |
| US4515893A (en) | 1979-04-26 | 1985-05-07 | Ortho Pharmaceutical Corporation | Hybrid cell line for producing complement-fixing monoclonal antibody to human T cells |
| US4560655A (en) | 1982-12-16 | 1985-12-24 | Immunex Corporation | Serum-free cell culture medium and process for making same |
| US4657866A (en) | 1982-12-21 | 1987-04-14 | Sudhir Kumar | Serum-free, synthetic, completely chemically defined tissue culture media |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| DD266710A3 (de) | 1983-06-06 | 1989-04-12 | Ve Forschungszentrum Biotechnologie | Verfahren zur biotechnischen Herstellung van alkalischer Phosphatase |
| US4767704A (en) | 1983-10-07 | 1988-08-30 | Columbia University In The City Of New York | Protein-free culture medium |
| JPS6150925A (ja) | 1984-08-17 | 1986-03-13 | Toray Ind Inc | 抗原または抗体の精製方法 |
| US4879231A (en) | 1984-10-30 | 1989-11-07 | Phillips Petroleum Company | Transformation of yeasts of the genus pichia |
| GB8516415D0 (en) | 1985-06-28 | 1985-07-31 | Celltech Ltd | Culture of animal cells |
| US5091178A (en) | 1986-02-21 | 1992-02-25 | Oncogen | Tumor therapy with biologically active anti-tumor antibodies |
| US4927762A (en) | 1986-04-01 | 1990-05-22 | Cell Enterprises, Inc. | Cell culture medium with antioxidant |
| GB8610600D0 (en) | 1986-04-30 | 1986-06-04 | Novo Industri As | Transformation of trichoderma |
| IL85035A0 (en) | 1987-01-08 | 1988-06-30 | Int Genetic Eng | Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same |
| ATE121418T1 (de) * | 1987-10-23 | 1995-05-15 | Schering Corp | Verfahren zur proteinreinigung. |
| US5091313A (en) | 1988-08-05 | 1992-02-25 | Tanox Biosystems, Inc. | Antigenic epitopes of IgE present on B cell but not basophil surface |
| US5720937A (en) | 1988-01-12 | 1998-02-24 | Genentech, Inc. | In vivo tumor detection assay |
| JP2749167B2 (ja) | 1988-06-21 | 1998-05-13 | ジェネンテク，インコーポレイテッド | 心筋梗塞の処置のための方法および治療用組成物 |
| WO1990003430A1 (en) | 1988-09-23 | 1990-04-05 | Cetus Corporation | Cell culture medium for enhanced cell growth, culture longevity and product expression |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| JP2844346B2 (ja) | 1989-05-31 | 1999-01-06 | 昭 梶 | 新規ペプチドならびに新規ｄｎａ |
| EP0402226A1 (en) | 1989-06-06 | 1990-12-12 | Institut National De La Recherche Agronomique | Transformation vectors for yeast yarrowia |
| DE3920358A1 (de) | 1989-06-22 | 1991-01-17 | Behringwerke Ag | Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung |
| US5122469A (en) | 1990-10-03 | 1992-06-16 | Genentech, Inc. | Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins |
| EP1260521B1 (en) | 1991-08-14 | 2007-11-21 | Genentech Inc. | Immunoglobulin variants for specific Fc epsilon receptors |
| DE69233528T2 (de) | 1991-11-25 | 2006-03-16 | Enzon, Inc. | Verfahren zur Herstellung von multivalenten antigenbindenden Proteinen |
| CA2372813A1 (en) | 1992-02-06 | 1993-08-19 | L.L. Houston | Biosynthetic binding protein for cancer marker |
| CA2140933A1 (en) | 1992-08-21 | 1994-02-22 | Paula M. Jardieu | Method for treating an lfa-1 mediated disorder |
| US5736137A (en) | 1992-11-13 | 1998-04-07 | Idec Pharmaceuticals Corporation | Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma |
| US5595721A (en) | 1993-09-16 | 1997-01-21 | Coulter Pharmaceutical, Inc. | Radioimmunotherapy of lymphoma using anti-CD20 |
| JP4057049B2 (ja) | 1993-09-21 | 2008-03-05 | ヘモソル インコーポレーテッド | 置換クロマトグラフィー法および精製ヘモグロビン産物 |
| EP0733207B1 (en) | 1993-12-10 | 1997-08-27 | Genentech, Inc. | Methods for diagnosis of allergy and screening of anti-allergy therapeutics |
| AP660A (en) | 1994-01-18 | 1998-08-18 | Genentech Inc | A method of treatment of parasitic infection using IgE antagonists. |
| US5707622A (en) | 1994-03-03 | 1998-01-13 | Genentech, Inc. | Methods for treating ulcerative colitis |
| US5534615A (en) | 1994-04-25 | 1996-07-09 | Genentech, Inc. | Cardiac hypertrophy factor and uses therefor |
| IL117645A (en) | 1995-03-30 | 2005-08-31 | Genentech Inc | Vascular endothelial cell growth factor antagonists for use as medicaments in the treatment of age-related macular degeneration |
| US5641870A (en) | 1995-04-20 | 1997-06-24 | Genentech, Inc. | Low pH hydrophobic interaction chromatography for antibody purification |
| CA2222231A1 (en) | 1995-06-07 | 1996-12-19 | Imclone Systems Incorporated | Antibody and antibody fragments for inhibiting the growth of tumors |
| PT877626E (pt) | 1996-01-23 | 2003-01-31 | Univ Vermont And State Agric C | Anticorpos anti-cd1s para utilizacao contra icto |
| CA2242931A1 (en) | 1996-01-31 | 1997-08-07 | David Francis Elgar | Production of an immunoglobulin enriched fraction from whey protein solutions |
| US7147851B1 (en) | 1996-08-15 | 2006-12-12 | Millennium Pharmaceuticals, Inc. | Humanized immunoglobulin reactive with α4β7 integrin |
| AU731817C (en) | 1996-11-27 | 2001-11-01 | Genentech Inc. | Humanized anti-CD11a antibodies |
| DE69829891T2 (de) | 1997-04-07 | 2005-10-06 | Genentech, Inc., South San Francisco | Anti-VEGF Antikörper |
| PT981618E (pt) | 1997-05-15 | 2007-11-23 | Genentech Inc | ''anticorpo anti-apo-2'' |
| US6054293A (en) | 1997-07-08 | 2000-04-25 | The Regents Of The University Of California | Semaphorin receptors |
| US6946129B1 (en) | 1999-06-08 | 2005-09-20 | Seattle Genetics, Inc. | Recombinant anti-CD40 antibody and uses thereof |
| AR024464A1 (es) | 1999-06-25 | 2002-10-02 | Genentech Inc | Anticuerpos anti-erbb2 humanizados. |
| KR100490077B1 (ko) | 1999-10-29 | 2005-05-17 | 제넨테크, 인크. | 항-전립선 줄기세포 항원 (ｐｓｃａ) 항체 조성물 및 그의사용 방법 |
| JP2004504330A (ja) | 2000-07-13 | 2004-02-12 | インヴィトロジェン コーポレーション | 溶解マトリクスを用いてタンパク質およびペプチドの迅速な抽出および単離のための方法および組成物 |
| UA83458C2 (uk) | 2000-09-18 | 2008-07-25 | Байоджен Айдек Ма Інк. | Виділений поліпептид baff-r (рецептор фактора активації в-клітин сімейства tnf) |
| US7321026B2 (en) | 2001-06-27 | 2008-01-22 | Skytech Technology Limited | Framework-patched immunoglobulins |
| AU2002325755A1 (en) | 2001-09-18 | 2003-04-01 | Affinium Pharmaceuticals, Inc. | Methods and apparatuses for purification |
| AU2002332130A1 (en) | 2001-10-16 | 2003-04-28 | Exelixis, Inc. | Msrebps as modifiers of the srebp pathway and methods of use |
| CA2476675A1 (en) | 2001-10-17 | 2003-04-24 | Human Genome Sciences, Inc. | Neutrokine-alpha and neutrokine-alpha splice variant |
| US20040093621A1 (en) | 2001-12-25 | 2004-05-13 | Kyowa Hakko Kogyo Co., Ltd | Antibody composition which specifically binds to CD20 |
| CA2476166C (en) | 2002-02-14 | 2011-11-15 | Immunomedics, Inc. | Anti-cd20 antibodies and fusion proteins thereof and methods of use |
| KR100944575B1 (ko) | 2002-10-17 | 2010-02-25 | 젠맵 에이/에스 | Ｃｄ20에 대한 인간 모노클로날 항체 |
| HUE035898T2 (en) | 2002-12-16 | 2018-05-28 | Genentech Inc | Immunoglobulin variants and their applications |
| CN1206240C (zh) * | 2003-04-07 | 2005-06-15 | 中国科学院生态环境研究中心 | 高效离子交换膜色谱纯化卵黄蛋白原技术 |
| KR101351122B1 (ko) | 2003-05-09 | 2014-01-14 | 듀크 유니버시티 | Ｃｄ２０-특이적 항체 및 이를 이용한 방법 |
| AR044388A1 (es) | 2003-05-20 | 2005-09-07 | Applied Molecular Evolution | Moleculas de union a cd20 |
| CA2534898A1 (en) | 2003-08-08 | 2005-02-17 | Immunomedics, Inc. | Bispecific antibodies for inducing apoptosis of tumor and diseased cells |
| US8147832B2 (en) | 2003-08-14 | 2012-04-03 | Merck Patent Gmbh | CD20-binding polypeptide compositions and methods |
| US20080274501A1 (en) * | 2007-05-02 | 2008-11-06 | Chenming Zhang | Method of purifying acidic proteins expressed in plants |
| US9433922B2 (en) | 2007-08-14 | 2016-09-06 | Emd Millipore Corporation | Media for membrane ion exchange chromatography based on polymeric primary amines, sorption device containing that media, and chromatography scheme and purification method using the same |
| AU2008315124B2 (en) | 2007-10-26 | 2012-06-21 | Asahi Kasei Chemicals Corporation | Method for purifying protein |
| HUE024877T2 (en) | 2007-10-30 | 2016-02-29 | Genentech Inc | Antibody purification by cation exchange chromatography |
| WO2009135656A1 (en) * | 2008-05-06 | 2009-11-12 | Lonza Biologics Plc. | A method for the purification of antibodies using displacement chromatography |
| HUE066562T2 (hu) | 2008-08-14 | 2024-08-28 | Genentech Inc | Eljárások szennyezés eltávolítására indigén fehérje kiszorításos ioncserés membrán kromatográfia alkalmazásával |
| GB0816242D0 (en) | 2008-09-05 | 2008-10-15 | Immunobiology Ltd | Method of purifying protien complexes |
| EP4786482A2 (en) | 2009-08-06 | 2026-08-05 | F. Hoffmann-La Roche AG | Virus filtration methods |
| BR112012004697B8 (pt) | 2009-09-01 | 2021-05-25 | Genentech Inc | método para purificar um polipeptídeo compreendendo uma região ch2/ch3 |
| WO2011133886A2 (en) * | 2010-04-23 | 2011-10-27 | Genentech, Inc. | Production of heteromultimeric proteins |
| HRP20171095T4 (hr) | 2010-05-25 | 2022-07-22 | F. Hoffmann - La Roche Ag | Postupci pročišćavanja polipeptida |
| JP2014531604A (ja) * | 2011-10-03 | 2014-11-27 | サッチェム，インコーポレイテッド | 疎水性置換クロマトグラフィーのためのアニオン性置換剤分子 |
| PL2794635T3 (pl) * | 2011-12-22 | 2019-02-28 | F.Hoffmann-La Roche Ag | Membranowa chromatografia jonowymienna |
| JP5731726B1 (ja) | 2014-06-26 | 2015-06-10 | 楽天株式会社 | 情報処理装置、情報処理方法及び情報処理プログラム |
-
2012
- 2012-12-18 PL PL12806322T patent/PL2794635T3/pl unknown
- 2012-12-18 KR KR1020207000846A patent/KR20200008022A/ko not_active Ceased
- 2012-12-18 EP EP18193475.3A patent/EP3492486A1/en active Pending
- 2012-12-18 HR HRP20181846TT patent/HRP20181846T1/hr unknown
- 2012-12-18 JP JP2014549204A patent/JP6605202B2/ja active Active
- 2012-12-18 EP EP12806322.9A patent/EP2794635B8/en active Active
- 2012-12-18 SI SI201231443T patent/SI2794635T1/sl unknown
- 2012-12-18 SG SG11201403437TA patent/SG11201403437TA/en unknown
- 2012-12-18 CN CN201810818291.3A patent/CN108892706A/zh active Pending
- 2012-12-18 IL IL267585A patent/IL267585B/en unknown
- 2012-12-18 KR KR1020147019968A patent/KR102067075B1/ko active Active
- 2012-12-18 TR TR2018/15709T patent/TR201815709T4/tr unknown
- 2012-12-18 BR BR112014015101A patent/BR112014015101A8/pt not_active Application Discontinuation
- 2012-12-18 KR KR1020217005616A patent/KR20210025692A/ko not_active Ceased
- 2012-12-18 MY MYPI2014701665A patent/MY172426A/en unknown
- 2012-12-18 CA CA2859376A patent/CA2859376C/en active Active
- 2012-12-18 WO PCT/US2012/070373 patent/WO2013096322A1/en not_active Ceased
- 2012-12-18 RU RU2014130017A patent/RU2648999C2/ru active
- 2012-12-18 ES ES12806322T patent/ES2697676T3/es active Active
- 2012-12-18 CN CN201280070369.9A patent/CN104125963B/zh active Active
- 2012-12-18 US US14/365,449 patent/US10364268B2/en active Active
- 2012-12-18 MX MX2014007622A patent/MX360453B/es active IP Right Grant
- 2012-12-18 AU AU2012355356A patent/AU2012355356B2/en active Active
- 2012-12-20 AR ARP120104862A patent/AR089362A1/es not_active Application Discontinuation
-
2014
- 2014-06-16 IL IL233158A patent/IL233158B/en active IP Right Grant
- 2014-06-20 MX MX2018013356A patent/MX2018013356A/es unknown
- 2014-06-23 ZA ZA2014/04593A patent/ZA201404593B/en unknown
-
2018
- 2018-01-10 AU AU2018200194A patent/AU2018200194B2/en active Active
- 2018-02-13 JP JP2018023128A patent/JP2018109024A/ja not_active Withdrawn
-
2019
- 2019-06-06 US US16/433,763 patent/US11945837B2/en active Active
- 2019-06-20 ZA ZA2019/03994A patent/ZA201903994B/en unknown
- 2019-10-24 JP JP2019193276A patent/JP7402011B2/ja active Active
-
2020
- 2020-02-14 AU AU2020201070A patent/AU2020201070A1/en not_active Abandoned
-
2021
- 2021-06-22 JP JP2021102974A patent/JP7359807B2/ja active Active
-
2022
- 2022-03-25 JP JP2022050501A patent/JP2022101557A/ja active Pending
-
2024
- 2024-03-01 US US18/593,665 patent/US20240247027A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020040952A5 (enExample) | ||
| KR101569783B1 (ko) | 항체의 정제 방법 | |
| US8217153B2 (en) | Methods and systems for isolating target molecules from complex solutions by column-chromatography using wash solutions containing organic solvents | |
| JP2007532477A5 (enExample) | ||
| Gao et al. | Evaluating antibody monomer separation from associated aggregates using mixed-mode chromatography | |
| US20100069617A1 (en) | Enhanced protein aggregate removal by mixed mode chromatography on hydrophobic interaction media in the presence of protein-excluded zwitterions | |
| RU2014130017A (ru) | Способы повышения эффективности этапов очистки белка, находящихся ниже по потоку, с использованием мембранной ионообменной хроматографии | |
| US20110166332A1 (en) | Enhanced antibody aggregate removal with capto adhere in the presence of protein-excluded zwitterions | |
| RU2007112991A (ru) | Способ очистки антител | |
| WO2007075283A2 (en) | Polishing steps used in multi-step protein purification processes | |
| JP2018516229A5 (enExample) | ||
| US20230167416A1 (en) | A method for separation or depletion of empty aav capsids from full aav capsids | |
| HRP20192217T1 (hr) | ULTRA-PROČIŠĆENI DsbA I DsbC TE POSTUPCI NJIHOVE IZRADE I UPORABE | |
| Simó et al. | Performance of combinatorial peptide libraries in capturing the low-abundance proteome of red blood cells. 1. Behavior of mono-to hexapeptides | |
| RU2018121653A (ru) | Улучшенное разделение белков при ионообменной хроматографии | |
| CA2787009A1 (en) | Surface neutralization of apatite | |
| RU2018121657A (ru) | ПРОТИВОПОЛОЖНЫЕ ГРАДИЕНТЫ pH-СОЛЬ ДЛЯ УЛУЧШЕННОГО РАЗДЕЛЕНИЯ БЕЛКОВ | |
| CN116234619A (zh) | 宿主细胞dna的金属亲和提取 | |
| Ma et al. | Using precipitation by polyamines as an alternative to chromatographic separation in antibody purification processes | |
| Pavan et al. | The effect of NaCl on the adsorption of human IgG onto CM-Asp–PEVA hollow fiber membrane-immobilized nickel and cobalt metal ions | |
| Kotasińska et al. | Cation exchange displacement batch chromatography of proteins guided by screening of protein purification parameters | |
| Bresolin et al. | Adsorption of human serum proteins onto TREN-agarose: Purification of human IgG by negative chromatography | |
| US8741619B1 (en) | Method for purifying protein aqueous | |
| US8653239B2 (en) | Method for isolating polypeptides | |
| CN120309683A (zh) | 一种使用Protein A亲和层析纯化抗体的方法及其应用 |